Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 391 AL 405

Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: effect of different processing and analysis approaches on sample sizes

Teipel SJ, Peters O, Heuser I, Jessen F, Maier W, Froelich L, Arlt S, Hüll M, Gertz HJ, Kornhuber J, Wiltfang J, Thome J, Rienhoff O, Meindl T, Hampel H, Grothe M.

World J Biol Psychiatry. 2011 Sep;12 Suppl 1:109-13. doi: 10.3109/15622975.2011.603222.

Chronic divalproex sodium use and brain atrophy in Alzheimer disease

Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14.

Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations

Quintero-Monzon O, Martin MM, Fernandez MA, Cappello CA, Krzysiak AJ, Osenkowski P, Wolfe MS.

Biochemistry. 2011 Oct 25;50(42):9023-35. doi: 10.1021/bi2007146. Epub 2011 Sep 30.

Brain aging, Alzheimer's disease, and mitochondria

Swerdlow RH.

Biochim Biophys Acta. 2011 Dec;1812(12):1630-9. doi: 10.1016/j.bbadis.2011.08.012. Epub 2011 Sep 2.

[Current trend of immunotherapy for Alzheimer's disease]

Matsumoto SE, Tabira T.

Nihon Rinsho. 2011 Sep;69(9):1628-32.

Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine

Anekonda TS, Quinn JF.

Biochim Biophys Acta. 2011 Dec;1812(12):1584-90. doi: 10.1016/j.bbadis.2011.08.013. Epub 2011 Sep 8.

Therapeutic compliance of nanomedicine in Alzheimer's disease

Wilson B.

Nanomedicine (Lond). 2011 Sep;6(7):1137-9. doi: 10.2217/nnm.11.114.

Antioxidant pathways in Alzheimer's disease: possibilities of intervention

Viña J, Lloret A, Giraldo E, Badia MC, Alonso MD.

Curr Pharm Des. 2011 Dec;17(35):3861-4. doi: 10.2174/138161211798357755.

Emerging roles of pathogens in Alzheimer disease

Miklossy J.

Expert Rev Mol Med. 2011 Sep 20;13:e30. doi: 10.1017/S1462399411002006.

A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings

Roach KE, Tappen RM, Kirk-Sanchez N, Williams CL, Loewenstein D.

J Geriatr Phys Ther. 2011 Apr-Jun;34(2):50-6. doi: 10.1519/JPT.0b013e31820aab9c.

A prospective study of nutrition education and oral nutritional supplementation in patients with Alzheimer's disease

Pivi GA, da Silva RV, Juliano Y, Novo NF, Okamoto IH, Brant CQ, Bertolucci PH.

Nutr J. 2011 Sep 26;10:98. doi: 10.1186/1475-2891-10-98.

RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's disease

Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling AL, Matveev SV, LeVine H 3rd, Lovell MA, Murphy MP.

PLoS One. 2011;6(9):e24930. doi: 10.1371/journal.pone.0024930. Epub 2011 Sep 20.

Dementia with Lewy bodies is associated with higher scores on the Geriatric Depression Scale than is Alzheimer's disease

Yamane Y, Sakai K, Maeda K.

Psychogeriatrics. 2011 Sep;11(3):157-65. doi: 10.1111/j.1479-8301.2011.00368.x.

Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease

Apostolova LG, Hwang KS, Medina LD, Green AE, Braskie MN, Dutton RA, Lai J, Geschwind DH, Cummings JL, Thompson PM, Ringman JM.

Dement Geriatr Cogn Disord. 2011;32(2):118-25. doi: 10.1159/000330471. Epub 2011 Sep 23.

Use of memantine for the treatment of dementia

Lo D, Grossberg GT.

Expert Rev Neurother. 2011 Oct;11(10):1359-70. doi: 10.1586/ern.11.132.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias